迪瑞医疗收盘下跌1.52%，滚动市盈率108.77倍，总市值38.94亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Di Rui Medical, indicating a significant decline in revenue and profit in the latest quarterly report [1][2] - Di Rui Medical's closing stock price is 14.28 yuan, with a PE ratio of 108.77, which is substantially higher than the industry average of 51.83 and the median of 37.23 [1][2] - The total market capitalization of Di Rui Medical is 3.894 billion yuan, ranking it 107th in the medical device industry based on PE ratio [1][2] Group 2 - As of the first quarter of 2025, five institutions hold shares in Di Rui Medical, with a total of 115.7415 million shares valued at 1.690 billion yuan [1] - The company specializes in the research, production, marketing, and service of medical testing instruments and related reagents, with a total of 213 patents, including 136 invention patents [1] - The latest financial results show that Di Rui Medical achieved an operating income of 182 million yuan, a year-on-year decrease of 72.47%, and a net profit of 15.6787 million yuan, down 87.13%, with a gross profit margin of 42.78% [1]